CD200 signaling has been discussed for decades as an important mechanism in neuroinflammatory conditions (Neumann, 2001), but the jury is still out on whether CD200 could be important target to use in ischemic brain injury and neurodegenerative diseases. The gene discussed is CD200; the disease is neurodegenerative disease.